BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results
- NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended June 30, 2023. The Company reported a significant increase in gross margin underlining the ongoing success of its business strategy and operational effectiveness.
- 11/27/2023
|
BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch
- NEW YORK, NY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Phenix Bio Inc., a wholly owned subsidiary of BIMI International Medical Inc. (NASDAQ: BIMI), a leading global healthcare provider, announces the official launch of its "CUCA 3.0 Product Line through China Duty Free Group's (CDFG) online mini program sales platform. This significant milestone means China Duty Free's 26 million members can now purchase Phenix's products directly from CDFG, solidifying the previous purchase agreement between Phenix and CDFG, which became effective on August 1, 2023.
- 11/08/2023
|
BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor
- NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company (“Hao Mu”), as its exclusive distributor responsible for the distribution of Phenix's 17 herbal supplements in Hong Kong, Taiwan and Macau.
- 10/30/2023
|
BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Mainland China Non-Exclusive Distributor
- NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company (“Hao Mu”), as a distributor responsible for the distribution of Phenix's 17 herbal supplements in Mainland China.
- 10/30/2023
|
BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of ASEAN Exclusive Distributor
- NEW YORK, NY, Sept. 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider today announced its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company, as its exclusive distributor responsible for the distribution of Phenix's 17 herbal supplements throughout the Association of Southeast Asian Nations (ASEAN) 10 member countries.
- 09/22/2023
|
BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”) today announced that on August 22, 2023, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Form 10-Q”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Nasdaq letter has no immediate effect on the listing of the Company's shares.
- 08/24/2023
|
BIMI International Medical Inc. Announces Strategic Partnership by its Phenix Bio Inc. Subsidiary with China Duty Free Group
- NEW YORK, NY, Aug. 07, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a leading global provider of healthcare services and innovative medical solutions, today announced the formation of a strategic partnership between its subsidiary, Phenix Bio Inc. (“Phenix”) and China Duty Free Group (“CDFG”), one of the largest and most influential state-owned duty-free retail enterprises in China.
- 08/07/2023
|
BIMI International Medical (BIMI) Stock: Why The Price Jumped Today
- The stock price of BIMI International Medical Inc. (NASDAQ: BIMI) increased by over 15% pre-market today. This is why it happened.
- 11/26/2021
|
3 Penny Stocks That Retail Traders Are Buying Right Now
- Are these penny stocks worth watching right now? The post 3 Penny Stocks That Retail Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 11/16/2021
|
PLBY Stock: 6 Reasons Why Playboy Owner's Shares Are Looking Sexy Today
- Playboy (PLBY) stock is hopping higher on Tuesday as investors react to results from the risque company's most recent earnings report. The post PLBY Stock: 6 Reasons Why Playboy Owner's Shares Are Looking Sexy Today appeared first on InvestorPlace.
- 11/16/2021
|
BIMI Stock: 10 Things to Know About BIMI International Medical as Shares Rocket
- BIMI International Medical (BIMI) stock is on the rise Tuesday and we're diving into all the latest details about the company. The post BIMI Stock: 10 Things to Know About BIMI International Medical as Shares Rocket appeared first on InvestorPlace.
- 11/16/2021
|
Bimi International Medical (BIMI) Stock: Why The Price Surged Today
- The stock price of Bimi International Medical Inc (NASDAQ: BIMI) increased by over 60% pre-market today. This is why it happened.
- 11/16/2021
|
Best Penny Stocks to Buy Now? 3 to Add to Your Watchlist Next Week
- Are these penny stocks worth watching next week? The post Best Penny Stocks to Buy Now?
- 11/05/2021
|
5 Penny Stocks To Buy For Under $1 On Webull Right Now
- Are these Webull penny stocks to buy or avoid right now? The post 5 Penny Stocks To Buy For Under $1 On Webull Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 11/03/2021
|
4 Top Penny Stocks to Watch With November Around The Corner
- Which penny stocks are on your November watchlist? The post 4 Top Penny Stocks to Watch With November Around The Corner appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 10/28/2021
|
Best Penny Stocks to Buy For The Meme Stock Rally? 3 to Watch
- These penny stocks rallied today, are they worth watching? The post Best Penny Stocks to Buy For The Meme Stock Rally?
- 09/29/2021
|
BIMI International Medical Inc. Signs Stock Purchase Agreement to Acquire Chongqing Zhuoda Pharmaceutical Co., Ltd.
|
BIMI International Medical Inc. Announces Appointment of New Chief Financial Officer
- NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider in China, today announced the appointment of Amy Xue as the Company's new Chief Financial Officer, effective July 15, 2021.
- 07/19/2021
|
BIMI International Medical Inc. Announces Corporate Name Change
- NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider in China, today announced that on June 15, 2021, the shareholders of the Company approved an amendment to the Company's certificate of incorporation to change the Company's name from BOQI International Medical Inc. to BIMI International Medical Inc. The Company's common stock traded under the new name and the same symbol “BIMI”.
- 06/28/2021
|
BIMI Stock Price Increased Over 5% Pre-Market: Why It Happened
- The stock price of BOQI International Medical Inc (NASDAQ: BIMI) is trading at over 5% pre-market. This is why it happened.
- 03/29/2021
|
BOQI International Medical Inc. Enters into MOU to Acquire 3 Hospitals
- NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announces the signing of a Memorandum of Understanding (“MOU”) with two individual sellers (“Sellers”) on March 24, 2021, with the intent of acquiring three hospitals, Yunnan Yuxi Minkang Hospital, Wuzhou Qiangsheng Hospital, and Suzhou Eurasia Hospital (“Hospitals”). The Sellers own 100% of the shares of these three companies.
- 03/25/2021
|
Correction: BOQI International Medical Raised $4.5 Million In A Private Placement of Senior Convertible Notes
- NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it closed a private placement of $5,400,000 of its senior convertible notes (the “Convertible Notes”) to two existing institutional investors (the “Investors”). The closing took place on February 26, 2021.
- 03/01/2021
|
BOQI International Medical Raised $4.5 Million In A Private Placement of Senior Convertible Notes
- NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it closed a private placement of $5,400,00 of its senior convertible notes (the “Convertible Notes”) to two existing institutional investors (the “Investors”). The closing took place on February 26, 2021.
- 03/01/2021
|
BOQI International Medical Enters into An Amendment to the Securities Purchase Agreement to Increase the Principal Amount of Senior Convertible Promissory Notes to Be Purchased by Two Institutional Investors
- NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announces that it has entered into an amendment to the Securities Purchase Agreement with two institutional investors (the “Investors”) that was previously announced on May 19, 2020. The Amendment increases the principal amount of senior convertible promissory notes to be purchased by the Investors.
- 02/24/2021
|
BOQI International Medical Announces Closing of the Acquisition of Chaohu Zhongshan Minimally Invasive Hospital
- New York, Feb. 10, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it had completed the acquisition of Chaohu Zhongshan Minimally Invasive Hospital (“Zhongshan Hospital”).
- 02/10/2021
|
BOQI International Medical Announces Closing of the Acquisition of Chongqing Guoyitang Hospital
- NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it had completed the acquisition of Chongqing Guoyitang Hospital Co., Ltd. (“Guoyitang”).
- 02/08/2021
|
BOQI International Medical Announces Receipt of $1.7 Million from Closing of the Sale of One of Its Pharmacy Chains
- NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the closing of the previously announced sale of its BOQI Zhengji Pharmacy Chain (“Zhengji Pharmacy”). The transaction closed on February 2, 2021, at which time the Company received the agreed upon consideration of US$ 1,700,000.
- 02/05/2021
|
BOQI International Medical Signs Material Definitive Agreement to Acquire Chaohu Zhongshan Minimally Invasive Hospital
- New York, Dec. 16, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a Stock Purchase Agreement (the “Agreement”) on December 15, 2020, to acquire Chaohu Zhongshan Minimally Invasive Hospital (“Zhongshan Hospital”), a private hospital in the southeast region of China with 65 hospital beds, 25 medical doctors, 22 medical technicians and 45 nurses. Zhongshan Hospital is a general hospital known for its complex minimally invasive surgeries.
- 12/16/2020
|
BOQI International Medical Signs Stock Purchase Agreement to Acquire Chongqing Cogmer Biology Technology Co., Ltd.
- New York, Dec. 15, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has signed a Stock Purchase Agreement (the “Agreement”) on December 14, 2020, to acquire Chongqing Cogmer Biology Technology Co., Ltd. (“Cogmer”), a distributor of medical devices including in vitro diagnostic devices. Cogmer is focused on sales to hospitals and sub-distributors in the southwest region of China.
- 12/15/2020
|
BOQI International Medical Inc. to Sell One of Its Pharmacy Chain
- New York, Dec. 14, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has signed definitive agreements to sell BOQI Zhengji Pharmacy Chain Co., Ltd. (“Zhengji Pharmacy”), the owner and operator of 16 pharmacies in the city of Dalian of China.
- 12/14/2020
|
BOQI International Medical Enters into Stock Purchase Agreement to Acquire Chongqing Guoyitang Hospital
- New York, Dec. 09, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a Stock Purchase Agreement (the “Agreement”) on December 7, 2020, to acquire Chongqing Guoyitang Hospital (“Guoyitang”), the owner and operator of a private general hospital in Chongqing City, a southwest city of China, with 100 hospital beds, 53 medical doctors, 40 medical technicians, 50 nurses and 57 administrative employees.
- 12/09/2020
|
BOQI International Medical Inc. Enters into MOU to Acquire Chaohu Zhongshan Minimally Invasive Hospital
- NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announces the signing of a Memorandum of Understanding (MOU) with Chaohu Zhongshan Minimally Invasive Hospital (“Chaohu Hospital”) on November 27, 2020.
- 11/30/2020
|
BOQI International Medical Inc. Announces Third Quarter 2020 Financial Results
- NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced its financial results for the third quarter and nine months ended September 30, 2020.
- 11/16/2020
|
Update: BOQI International Medical Forms New Subsidiary, BOYI Technology, To Generate Revenue in Healthcare Technology Industry
- NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today provided an update on the development of an eProcurement platform, supply-chain-management software and telemedicine software for the healthcare industry by its wholly-owned subsidiary, Dalian BOYI Technology Co., Ltd.
- 11/06/2020
|
Power Energy Saving Services Market 2020 Insights and Precise Outlook -GE (NYSE: GE), Honeywell, Enel, Engie, Johnson Controls
- Oct 02, 2020 (Market Insight Reports) --
Global Power Energy Saving Services Market Research Report 2020 begins with an overview of the Market and offers...
- 10/02/2020
|
LD Micro - Announces Preliminary List of Presenters for the LD-500.
- LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
- 08/05/2020
|
BOQI International Medical Announces Shareholder Approval of Issuance of Securities
- New York, July 27, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) announced that at the Company’s Annual Meeting of Shareholders held on July 24, 2020, its shareholders overwhelmingly voted to approve, in accordance with Nasdaq Marketplace Rule 5635(d), the issuance of shares of the Company’s common stock upon (i) conversion of $4.45 million of senior secured convertible notes sold to two institutional investors (the “Institutional Investors”) on June 2, 2020; (ii) conversion of up to $2.10 million of additional senior secured convertible notes that may be sold to the Institutional Investors; (iii) exercise of up to 1,300,000 warrants issued to the Institutional Investors; and (iv) exercise of warrants to initially purchase 171,845 shares of the Company’s common stock, subject to increase under certain circumstances, to the placement agent for the private placement of the above securities to the Institutional Investors.About BOQI International Medical Inc.BOQI International Medical Inc. (formerly known as NF Energy Saving Corporation) (NASDAQ: BIMI) was founded in 2006. In February 2019, the Board of Directors of the company was reorganized following efforts led by Mr. Yongquan Bi, the company’s new Chairman, with a renewed focus on the health industry. The company is now transforming from a provider of integrated energy conservation solutions to a healthcare products provider. BOQI International Medical Inc. offers a broad range of healthcare products and related services.Safe Harbor StatementThe statements contained herein that are not historical facts are considered “forward-looking statements.” Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” or “anticipates” or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, statements regarding the efficacy of investment in research and development are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the effect of political, economic, and market conditions and geopolitical events; the impact of COVID-19; legislative and regulatory changes that affect our business; the availability of funds and working capital; the actions and initiatives of current and potential competitors; investor sentiment; and our reputation. We do not undertake any responsibility to publicly release any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this report. Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events, which may cause actual results to differ from those expressed or implied by any forward-looking statements. The factors discussed herein are expressed from time to time in our filings with the Securities and Exchange Commission available at http://www.sec.gov.IR Contact: Dragon Gate Investment Partners LLC Tel: +1(646)-801-2803 Email: BIMI@dgipl.com
- 07/27/2020
|
NF Energy Saving (NASDAQ:BIMI) Upgraded by ValuEngine to “Buy”
- NF Energy Saving (NASDAQ:BIMI) was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Friday, ValuEngine reports. NASDAQ:BIMI opened at $2.11 on Friday. The firm’s fifty day simple moving average is $2.70 and its 200 day simple moving average is $3.01. NF Energy Saving has […]
- 07/03/2020
|
BOQI International Medical Announces First Quarter 2020 Financial Results
- NEW YORK, June 29, 2020 -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced its financial results for the fiscal quarter ended March 31,.
- 06/29/2020
|
BOQI International Medical Announces Closing of Energy Business Spin-Off
- As previously disclosed, on March 31, 2020, the Company entered into a Stock Purchase Agreement (the “Purchase Agreement”) pursuant to which the Company agreed to sell its legacy energy saving enhancement business conducted through NF Energy Saving Investment Limited and its subsidiaries for $10 million in cash. "The divestiture of the energy saving enhancement business is a key milestone in our strategy to refine our focus," said Mr. Tiewei Song, Chief Executive Officer and President of BOQI International Medical Inc. "The sale allows us to concentrate on our stronger growth and higher-margin operations in the healthcare business while reducing costs and strengthening our financial position."
- 06/24/2020
|
Parametric Portfolio Associates LLC Sells 248,895 Shares of Korea Electric Power Co. (NYSE:KEP)
- Parametric Portfolio Associates LLC decreased its stake in Korea Electric Power Co. (NYSE:KEP) by 12.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,741,829 shares of the utilities provider’s stock after selling 248,895 shares during the period. Parametric Portfolio Associates LLC owned 0.14% of […]
- 06/14/2020
|
BOQI International Medical Announces Closing of Previously Announced Sale of Senior Secured Convertible Notes and Warrants
- Additional Convertible Notes in an aggregate original principal amount not to exceed $2,100,000 may also be issued to the institutional investors at a later date under certain circumstances. The Convertible Notes do not bear interest except upon the occurrence of an event of default.
- 06/04/2020
|
Correction: BOQI International Medical Enters into Securities Purchase Agreement
- In a release issued under the same headline on May 19, 2020 by BOQI International Medical Inc. (BIMI), in the third paragraph, the discount to the amortization conversion price should have been 22%, not 78%. The offering is subject to customary closing conditions and is expected to close on or about May 22, 2020.
- 05/19/2020
|
BOQI International Medical Enters into Securities Purchase Agreement
- Pursuant to the SPA, two convertible notes in an aggregate original principal amount of $ 4,450,000 will be issued to the investors, together with the issuance of warrants to acquire common stock of the Company. Each note has a face amount of $2,225,000, for which each holder will pay $1,750,000 in cash.
- 05/19/2020
|
BOQI International Medical Enters into MOU to acquire Chongqing Shanfeng Zhiyuan Biotechnology
- Chongqing Shanfeng Zhiyuan is an innovator, manufacturer and supplier of medical devices, disinfection supplies and cosmetics in Southwest China. It has a manufacturing plant covering about 18,298 square feet and has 51 employees including a 6-person R&D; team.
- 05/18/2020
|
BOQI International Medical Announces Fiscal Year 2019 Financial Results
- NEW YORK, May 15, 2020 -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) announced its financial results for the fiscal year ended December 31, 2019..
- 05/15/2020
|
The Dawn Of The Hydrogen Economy II: The Future Of Energy Storage And Smart Cities
- Development in energy storage to accelerate energy conversion. Tesla’s solar panel installation and energy storage through ESS help enhance economic feasibility
- 05/06/2020
|
BYND, OPK among premarket gainers
- Energous (NASDAQ:WATT) +143% on FCC certification.Vaxart (NASDAQ:VXRT) +32% on encouraging COVID-19 vaccine data.My Size (NASDAQ:MYSZ) +27%.Applied DNA Sciences (NASDAQ:APDN) +21% on deal for COVID-19
- 04/21/2020
|
BOQI International Medical Enters into MOU with Dalian Shengshi Nianhua Hospital to Develop Telemedicine System
- New York, April 21, 2020 -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a Memorandum of Understanding.
- 04/21/2020
|
APHA, AAL among premarket gainers
- Applied DNA Sciences (NASDAQ:APDN) +61% on advancement of COVID-19 vaccine candidates.Comstock Holding Companies (NASDAQ:CHCI) +45% on FY results.BOQI International Medical (NASDAQ:BIMI) +25% on formi
- 04/15/2020
|
BOQI International Medical Forms New Subsidiary to Expand Pharmacy Chain Business in Southwest China
- Chongqing Shude is a medical distributor with distribution channels covering more than 4,000 pharmacies. The establishment of the new pharmacy chain subsidiary is expected to attract Chongqing Shude’s independent pharmacy clients to join the pharmacy chain.
- 04/15/2020
|
NVAX, INSG among premarket gainers
- InflaRx N.V. (NASDAQ:IFRX) +54% with doses of first COVID-19 with IFX-1.Qumu (NASDAQ:QUMU) +39%.Chembio Diagnostics (NASDAQ:CEMI) +26% on launching rapid COVID-19 blood test.Safe-T Group (NASDAQ:SFET)
- 04/01/2020
|
BOQI International Medical Announces Stock Purchase Agreement to Spin Off its Energy Business
- On March 31, 2020, the Company entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Yunfei Lu, a citizen of the People’s Republic of China (the “PRC”) (“Buyer”), pursuant to which the Company will sell, convey and transfer its legacy business, through the sale of all the issued and outstanding shares of the capital stock of NF ENERGY SAVING INVESTMENT LIMITED, a company organized under the laws of the British Virgin Islands (“Parent”) (the "Asset Sale") to Buyer. Parent owns, indirectly, all the issued and outstanding shares of the capital stock of LIAONING NENGFA WEIYE ENERGY TECHNOLOGY CO., LTD., a company organized under the laws of the PRC (the “Target”). The closing of the Purchase Agreement is expected to be in or about May, 2020.
- 04/01/2020
|
BOQI International Medical Announces Stock Purchase Agreement to Spin Off its Energy Business
- New York, April 01, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered...
- 04/01/2020
|
TLRY, HEXO among premarket gainers
- Astrotech (NASDAQ:ASTC) +59% as breathTest-1000 confirmed to detect lung disease metabolites at parts per billion.MFA Financial (NYSE:MFA) +26%.Hoth Therapeutics (NASDAQ:HOTH) +22% on agreement with V
- 03/27/2020
|
BOQI International Medical Announces $10 Million Medical Device Purchase Agreement with Chongqing Kegemo Biotechnology
- Under the terms of the agreement, Chongqing Kegemo agreed to purchase 100,000 medical isolation gowns, 60,000 disposable protective coveralls, 10 Philips CT machines, 300 noninvasive ventilators, 10 digital radiography systems and 50 digital laryngoscopes (the “Medical Devices”) from Chongqing Guanzan. The aggregate purchase price to be paid is RMB 75,254,000 (estimated at $10,637,960).
- 03/27/2020
|
Biotech and hospitality stocks among premarket gainers
- Bellerophon Therapeutics (NASDAQ:BLPH) +472% on FDA nod for emergency use of INOpulse for Covid-19.Rand Capital (NASDAQ:RAND) +87% on its portfolio company developing automated test kits for detection
- 03/20/2020
|
BOQI International Medical Announces $19 Million Medical Device Purchase Agreement with Shandong Forward Medical Group
- Under the terms of the agreement, Shandong Forward Medical agreed to purchase 90,000 medical isolation gowns, 100,000 disposable protective coveralls, 18 Philips CT machines, 500 noninvasive ventilators, 15 digital radiography systems and 55 digital laryngoscopes (the “Medical Devices”) from Chongqing Guanzan. The aggregate purchase price to be paid is RMB 137,885,000 (estimated at $19,648,735).
- 03/20/2020
|
BOQI International Medical Announces $19 Million Medical Device Purchase Agreement with Shandong Forward Medical Group
- New York, March 20, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that its...
- 03/20/2020
|
BOQI International Medical Completes Acquisition of Chongqing Guanzan Technology
- Chongqing Guanzan is a medical distributor with distribution channels covering over 4,000 pharmacies, over 4,000 clinics, 50 hospitals and 130 pharmaceutical companies nationwide. Chongqing Guanzan also has about ten world-leading medical device suppliers such as Stryker, GE, Siemens, Philips and Olympus.
- 03/19/2020
|
BOQI International Medical Completes Acquisition of Chongqing Guanzan Technology
- New York, March 19, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has...
- 03/19/2020
|
BOQI International Medical Updates Membership Program with Exclusive Benefits
- The company is also expanding its supply chains to ensure the customers have access to medical supplies during this time of need. On March 5, 2020, the Company entered into a purchase agreement with Nanjing Chuangling Environmental Technology Co., Ltd. (“Nanjing Chuangling”) through its wholly-owned subsidiary Boqi Zhengji Pharmacy Chain Co., Ltd. According to the agreement, Nanjing Chuangling is going to supply surgical masks and 75% rubbing alcohol to Boqi Zhengji Pharmacy’s multiple chain stores.
- 03/06/2020
|
Healthcare dominates premarket losers amidst coronavirus situation
- Spherix (NASDAQ:SPEX) -25%.Dynatronics (NASDAQ:DYNT) -22%.China Pharma Holdings (NYSEMKT:CPHI) -19%.Co-Diagnostics (NASDAQ:CODX) -17%.Tilray (NASDAQ:TLRY) -14% on Q4 earnings.Cleveland BioLabs (NASDAQ
- 03/03/2020
|
TSLA, TWTR among premarket gainers
- Daxor (NYSEMKT:DXR) +77% on coronavirus news.Forty Seven (NASDAQ:FTSV) +62% as Gilead Sciences makes $95.50 per share cash offer.Trillium Therapeutics (NASDAQ:TRIL) +51% as Gilead Sciences makes $95.5
- 03/02/2020
|
BOQI International Medical Announces Distributorship Agreement for Seradase in Southwest China
- BOQI International Medical is authorized as the exclusive distributor of Harmony’s Seradase Serrapeptase Enteric-coated Tablets(“Seradase”) in Southwest China. Seradase was included in the anti-epidemic supply list by Chongqing Economy and Information Technology Commission on February 25, 2020. The Chongqing Economy and Information Technology Commission is responsible for monitoring and analyzing industry trends and publishing relevant information.
- 03/02/2020
|
NVAX, SGMO among premarket gainers
- Dynatronics (NASDAQ:DYNT) +224%.Altimmune (NASDAQ:ALT) +143% on completing first development milestone toward a single-dose intranasal COVID-19 vaccine.Allied Healthcare Products (NASDAQ:AHPI) +103% a
- 02/28/2020
|
NVAX, INO among premarket gainers
- Allied Healthcare Products (NASDAQ:AHPI) +71%.GAIN Capital Holdings (NYSE:GCAP) +66% on Q4 results.Co-Diagnostics (NASDAQ:CODX) +66%.Alpha Pro Tech (NYSEMKT:APT) +48% after updating on orders.AIM Immu
- 02/27/2020
|
GILD, GOLD among premarket gainers
- NGM Biopharmaceuticals (NASDAQ:NGM) +67% after aldafermin phase 2 results.NanoViricides (NYSEMKT:NNVC) +39% on drugmakers working on coronavirus.Enlivex Therapeutics (NASDAQ:ENLV) +37% after disclosin
- 02/24/2020
|
BOQI International Medical Announces Xiaoping Wang As Chief Operating Officer
- As COO, Mr. Wang has responsibility for the company's supply chain and sourcing operations, demand planning, distribution, information technology, business process management, corporate real estate, asset protection and sustainability. Prior to joining BOQI International Medical, Mr. Xiaoping Wang has 15 years of executive experience in pharmaceutical companies. Mr. Wang is the Founder, Chairman and CEO of Chongqing Guanzan Technology Co., Ltd. (“Chongqing Guanzan”), and Chongqing Shude Pharmaceutical Co., Ltd. (“Chongqing Shude”) He utilized his expertise to scale the two companies and opened up significant distribution channels.
- 02/18/2020
|
INO, CRSP among premarket gainers
- CounterPath (NASDAQ:CPAH) +49% on securing five-year deal with Vodafone Fiji to extend superior quality voice services to consumers.Alpha Pro Tech (NYSEMKT:APT) +29% as orders surge for Alpha Pro Tech
- 02/13/2020
|
S, TMUS among premarket gainers
- Sprint (NYSE:S) +74% after judge approves T-Mobile merger.Rexahn Pharmaceuticals (NASDAQ:REXN) +25%.ZK International Group (NASDAQ:ZKIN) +21% on supplying stainless steel pipe and fitting products for
- 02/11/2020
|
BOQI International Medical Forms New Subsidiary, BOYI Technology, To Generate Revenue In Healthcare Technology Industry
- The formation of BOYI Technology is in line with BOQI International Medical’s member-centric O2O business model, while also meeting the increasing market demand for Telehealth software and healthcare SCMS. BOYI Technology will be based in Dalian, China, with initial product availability expected in the second quarter of the calendar year 2020.
- 02/11/2020
|
BOQI International Medical Amends Terms for Acquisition of Boqi Zhengji Pharmacy Chain
- According to the original purchase agreement signed on April 11, 2019, the aggregate purchase price for the shares of Boqi Pharmacy (or Boqi Pharmacy’s parent) consists of a cash consideration of RMB 40,000,000 (currently approximately US$5,714,285) (the “Target Cash Consideration”)and 1,500,000 shares of common stock of the Company. The Target Cash Consideration is subject to post-closing adjustment according to the appraised value of Boqi Pharmacy.
- 02/07/2020
|
Correction: BOQI International Medical Enters into Material Definitive Agreement to Acquire Chongqing Guanzan Technology
- In a release issued under the same headline on Monday, February 3, 2020 by BOQI International Medical Inc. (BIMI), in the third paragraph, the Cash Consideration to be paid should have been RMB 80,000,000 (currently approximately $11,428,571), not RMB 800,000,000. Chongqing Guanzan is a Chinese medical distributor with distribution channels covering over 4,000 pharmacies, over 4,000 clinics, 50 hospitals and 130 pharmaceutical companies nationwide.
- 02/04/2020
|
61 Stocks Moving In Monday's Mid-Day Session
- Gainers
China Pharma Holdings, Inc. (NYSE: CPHI) shares jumped 88% to $0.88 after gaining 11.50% on Friday.
Artelo Biosciences, Inc. (NASDAQ: ARTL) shares climbed 50.3% to $3.05...
- 02/03/2020
|
Forensic Value Stock Analysis: The Highest Positive And Negative Scoring Stocks For February
- The new February selections for both Positive and Negative Forensic Value stocks released in alternating months with the Piotroski-Graham Value selections. 11 P
- 02/03/2020
|
BOQI International Medical Enters into Material Definitive Agreement to Acquire Chongqing Guanzan Technology
- Chongqing Guanzan is a Chinese medical distributor with distribution channels covering over 4,000 pharmacies, over 4,000 clinics, 50 hospitals and 130 pharmaceutical companies nationwide. Chongqing Guanzan also has about ten world-leading medical device suppliers such as Stryker, GE, Siemens, Philips and Olympus.
- 02/03/2020
|
AMZN, NAV among premarket gainers
- Navistar International (NYSE:NAV) +55% with Volkswagen finally making move for acquisition.NanoViricides (NYSEMKT:NNVC) +42% after confirming work on coronavirus treatment.Lianluo Smart (NASDAQ:LLIT)
- 01/31/2020
|
BOQI International Medical Announces Actions Against Novel Coronavirus
- Since the epidemic of the novel coronavirus, the company has been actively contacting and negotiating with pharmaceutical manufacturers and wholesale companies, including the Sinopharm Group, CR Pharmaceutical Group Liaoning Branch, and Jointown Pharmaceutical Liaoning Branch.
- 01/29/2020
|
BOQI International Medical Renegotiates Purchase Price For Boqi Zhengji Pharmacy Chain Co., Ltd.
- According to the existing purchase agreement signed on April 11, 2019, the aggregate purchase price for the shares of Boqi Zhengji Pharmacy Chain (or Boqi Zhengji Pharmacy Chain’s parent) consists of a cash consideration of USD 5,643,181 (RMB 40,000,000) and 1,500,000 shares of common stock of the Company. The purchase price is based on an initial appraisal of the fair market value of the acquired company and is subject to post-closing adjustments.
- 01/14/2020
|
